ArticleJournal of the American Academy of Dermatology2021
Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19.
Article in Journal of the American Academy of Dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 40 citations in OpenAlex.
- Prevalence of skin manifestations in patients with COVID-19: a systematic review and meta-analysis.Frontiers in medicine · 2024Pooled it
- Oral Manifestations of COVID-19 in Hospitalized Patients: A Systematic Review.International journal of environmental research and public health · 2021Pooled it
- Oral Manifestations of COVID-19: Updated Systematic Review With Meta-Analysis.Frontiers in medicine · 2021Pooled it
- Silicone Breast Implant Rupture Triggered by Infection Leading to Skin Ulceration: A Case Report.Cureus · 2024Article
- Estimating the prevalence of oral manifestations in COVID-19 patients: a systematic review.Osong public health and research perspectives · 2023Article
- A case of COVID-19-related necrotic nasal ulceration.Clinical case reports · 2023Article
- Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil.Cureus · 2022Article
- The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.Dermatopathology (Basel, Switzerland) · 2022Review
- Dermatological Manifestations of COVID-19 in Children.Indian pediatrics · 2022Review
- Mucocutaneous manifestations among adults hospitalized with multisystem inflammatory syndrome following SARS-CoV-2 infection.JAAD international · 2022Article
- Necrotic lesions on the face in a patient with COVID-19.Journal de medecine vasculaire · 2022Article
- Article
- Article
- Cutaneous Manifestations of COVID-19 in the Inpatient Setting.Dermatologic clinics · 2021Review
- Ulcus vulvae acutum and SARS-CoV-2: an aetiological role?Journal of the European Academy of Dermatology and Venereology : JEADV · 2021Article
- Review
- Clinically amyopathic dermatomyositis during the COVID-19 pandemic.Oxford medical case reports · 2021Article
- Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.Clinical and experimental immunology · 2021Article
- Oral Complications of ICU Patients with COVID-19: Case-Series and Review of Two Hundred Ten Cases.Journal of clinical medicine · 2021Review
- Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLimited information exists on mucocutaneous disease and its relation to course of COVID-19.
objectiveTo estimate prevalence of mucocutaneous findings, characterize morphologic patterns, and describe relationship to course in hospitalized adults with COVID-19.
methodsProspective cohort study at 2 tertiary hospitals (Northwell Health) between May 11, 2020 and June 15, 2020.
resultsAmong 296 hospitalized adults with COVID-19, 35 (11.8%) had at least 1 disease-related eruption. Patterns included ulcer (13/35, 37.1%), purpura (9/35, 25.7%), necrosis (5/35, 14.3%), nonspecific erythema (4/35, 11.4%), morbilliform eruption (4/35, 11.4%), pernio-like lesions (4/35, 11.4%), and vesicles (1/35, 2.9%). Patterns also showed anatomic site specificity. A greater proportion of patients with mucocutaneous findings used mechanical ventilation (61% vs 30%), used vasopressors (77% vs 33%), initiated dialysis (31% vs 9%), had thrombosis (17% vs 11%), and had in-hospital mortality (34% vs 12%) compared with those without mucocutaneous findings. Patients with mucocutaneous disease were more likely to use mechanical ventilation (adjusted prevalence ratio, 1.98; 95% confidence interval, 1.37-2.86); P < .001). Differences for other outcomes were attenuated after covariate adjustment and did not reach statistical significance. LIMITATIONS: Skin biopsies were not performed.
conclusionsDistinct mucocutaneous patterns were identified in hospitalized adults with COVID-19. Mucocutaneous disease may be linked to more severe clinical course.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.